Latest Releases
Klobuchar, Smith Push for Improved Veteran Emergency Care
Washington, D.C.— Senators Amy Klobuchar, Tina Smith (both D-MN) and the entire Minnesota delegation sent a bicameral, bipartisan letter to Department of Veterans Affairs (VA) Secretary Denis McDonough urging the agency to improve veterans’ ability to receive emergency care. Specifically, the letter asks VA Secretary McDonough to revise existing rules to treat all emergency transport reimbursements the same way, regardless of a veteran’s service-connected disability rating. “By processing emergency transportation services as beneficiary travel, the VA leaves a large group of veterans with unpaid emergency transportation bills,” wrote the lawmakers. “This places an unjust burden on a population already facing rising medical costs across the board. From 2017 to 2020 alone, the cost to cover charges for emergency transportation services has risen at a rate of almost 18 percent.” “In light of the sacrifices our veterans have made, we must fulfill our obligation to provide those who have served this country with a high standard of care,” they continued. “While the VHA has played a critical role in providing necessary benefits for veterans, we call on the Administration to amend [these] regulations to provide the coverage of emergency transportation services that was intended under the VA Mission Act.” Under the 2018 VA Mission Act, emergency transportation and treatment at in-network, non-VA facilities became eligible for reimbursement. However, the VA is currently processing emergency land or air ambulance service claims as beneficiary travel, which restricts coverage to veterans with a disability rating (that is, the designation given to the severity of a
Klobuchar and Smith Announce Significant Federal Funding to Help Minnesotans with Heating and Energy Costs this Winter
WASHINGTON – U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN) announced that Congress approved more than $18 million in federal funding to help Minnesotan families afford their heating costs and utility bills this winter. “As Minnesota prepares for winter, families shouldn’t have to choose between heating their homes or buying other necessities,” said Klobuchar. “This federal funding will be critical to helping families and seniors across our state pay their energy bills and keep their homes warm. I’ll keep working to ensure Minnesotans have the support they need to stay safe this winter.” “As global energy markets respond to the pandemic and Putin’s war in Ukraine, we need to make sure Minnesotans have the support they need to heat their homes this winter,” said Smith. “For low-income families, high energy prices can force an impossible choice between heating their homes and other essentials like rent, food, or medicine. I’m proud of our work to secure this funding, which will help families in Minnesota afford their heating costs and utility bills in the coming months.” These resources will support the Low-Income Housing Energy Assistance Program (LIHEAP), which provides families with payment assistance to support their home energy needs. More than 127,000 households in Minnesotans received assistance with heating and cooling costs through LIHEAP last winter, with households receiving an average assistance benefit of $1,615. More information can be found by calling Minnesota’s Energy Assistance Program at 1-800-657-3710 or by visiting the website energyhelp.us.
Sens. Smith, Warren Raise Questions about Accuracy of Secretary Azar’s Testimony Blaming Pharmacy Benefit Managers for High Drug Prices
WASHINGTON, DC [08/17/18]—Today, U.S. Sens. Tina Smith (D-Minn.) and Elizabeth Warren (D-Mass.) questioned Health and Human Services (HHS) Secretary Alex Azar about his potentially misleading statements during his Senate testimony in which he blamed pharmacy benefit managers (PBMs) and drug distributors for drug manufacturers’ ongoing refusal to meaningfully reduce drug prices. The senators’ letter follows new information obtained from PBMs and drug distributors that directly contradicts the allegations made by Secretary Azar and raises questions about the accuracy of his testimony to Congress. Despite President Trump’s promises that drug companies would voluntarily enact “massive” price cuts, there have been no significant drug price
U.S. Sens. Tina Smith, Amy Klobuchar Honor the Storied Life of Minnesota’s First Female Member of Congress, Coya Knutson, with Senate Resolution
MINNESOTA [08/22/18]— Today, Minnesota’s U.S. Sens. Tina Smith and Amy Klobuchar honored the storied life of Minnesota’s first female member Congress, Coya Knutson, with a Senate Resolution heralding her life as a trailblazer who, despite great obstacles when she served in the 1950s, succeeded in making a difference for the families and communities in her state. You can read a copy of the Resolution here. The resolution, offered Wednesday on what would have been Knutson’s 106th birthday, notes that after arriving in Washington, D.C in 1954, she convinced Speaker Sam Rayburn to appoint her to be the first woman ever to serve on the House
Klobuchar, Smith, Reed Call on Administration to Protect U.S. Troops and Families from Financial Fraud
WASHINGTON – U.S. Senators Amy Klobuchar and Tina Smith joined Senator Jack Reed (D-RI) and 46 other senators in calling on the Consumer Financial Protection Bureau (CFPB) to maintain financial protections for servicemembers and their families under the Military Lending Act (MLA). Recent reports have indicated that the Administration is planning to stop examining lenders for violations of the MLA. In their letter, the senators urged CFPB Acting Director Mick Mulvaney not to end its examinations of payday lenders and other financial institutions for MLA compliance, and to not undertake measures that risk leaving U.S. troops and their families vulnerable to exploitation.
U.S. Sen. Tina Smith Presses Swiss Pharmaceutical Giant Novartis to Ensure Improper Company Actions Aren’t Pushing Up U.S. Prescription Drug Prices
WASHINGTON D.C. [08/23/18]— Today, U.S. Sen. Tina Smith (D-Minn.) pushed for answers from Swiss pharmaceutical giant Novartis on improper financial and lobbying efforts – including a $1.2 million dollar payment to President Trump’s former lawyer Michael Cohen – that could be contributing to high prescription drug prices for people in Minnesota and across the country. In May, Novartis confirmed that it erred when it paid Cohen through a shell company to help influence Trump Administration health care policy. Those payments came after Novartis had already agreed in 2016 to comply with a U.S. Securities and Exchange Commission (SEC) order to establish
English